ET-1 has been linked to lung fibrosis although ET-1 antagonist are ineffective in true fibrotic lung diseases like idiopathic pulmonary fibrosis, suggesting that ET-1 is part of a general lung remodeling pathway. Here, EDN1 is linked to pulmonary fibrosis.